(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMAS CRISTALINAS DE UM INIBIDOR DE RIPK1

Em AnáliseInvention PatentPCT · US2022052072

Application data

Number

112024010446

Type

Invention Patent

Filing

12/07/2022

Publication

09/03/2024

PCT

US2022052072

Progress at the INPI

  1. Filing12/07/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 12/07/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 09/03/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

RIGEL PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

S. D. (pessoa física)

US

S. S. (pessoa física)

US

X. W. (pessoa física)

US

Technical data

Priority claims

US

63/290,066 · 12/16/2021

Abstract

FORMAS CRISTALINAS DE UM INIBIDOR DE RIPK1.A presente invenção refere-se a um composto cristalino da fórmula, em que o composto cristalino é útil para o tratamento de doenças autoimunes e inflamatórias, tais como dermatite atópica, artrite reumatoide e psoríase.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

09/03/2024

RPI 2800

Alteração de dados cadastrais

#1.1

06/04/2024

RPI 2787

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.